僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Otilimab （GSK 3196165） is an anti-granulocyte-macrophage colony-stimulating factor （GM-CSF） humanized monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor